S&P 500

5.277,51

0,80%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Caribou Biosciences Inc (CRBU)
Caribou Biosciences Inc (CRBU) Notícias

CRBU

Caribou Biosciences (CRBU)

Caribou Biosciences Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:CRBU

1 2 3 4 5 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
30/05/2024	17:01	GlobeNewswire Inc.	Caribou Biosciences to Host KOL Discussion with Webcast from the 2024 ASCO Annual Meeting and Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
07/05/2024	17:11	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CRBU	Caribou Biosciences Inc
07/05/2024	17:05	GlobeNewswire Inc.	Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
01/05/2024	17:05	GlobeNewswire Inc.	Caribou Biosciences to Participate in Upcoming Investor Conferences	NASDAQ:CRBU	Caribou Biosciences Inc
24/04/2024	11:00	GlobeNewswire Inc.	Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting	NASDAQ:CRBU	Caribou Biosciences Inc
15/04/2024	10:00	GlobeNewswire Inc.	Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)	NASDAQ:CRBU	Caribou Biosciences Inc
04/04/2024	17:00	GlobeNewswire Inc.	Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus	NASDAQ:CRBU	Caribou Biosciences Inc
11/03/2024	18:08	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:CRBU	Caribou Biosciences Inc
11/03/2024	17:25	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:CRBU	Caribou Biosciences Inc
11/03/2024	17:05	GlobeNewswire Inc.	Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
05/03/2024	18:30	GlobeNewswire Inc.	Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting	NASDAQ:CRBU	Caribou Biosciences Inc
22/02/2024	19:28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
10/01/2024	18:18	Edgar (US Regulatory)	Form 3/A - Initial statement of beneficial ownership of securities: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
09/01/2024	18:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:CRBU	Caribou Biosciences Inc
08/01/2024	18:18	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:CRBU	Caribou Biosciences Inc
07/01/2024	13:00	GlobeNewswire Inc.	Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024	NASDAQ:CRBU	Caribou Biosciences Inc
13/12/2023	08:30	IH Market News	Cal-Maine Avian Flu Outbreak Impact, Amgen Hikes Dividend For Twelfth Year, and Latest Updates	NASDAQ:CRBU	Caribou Biosciences Inc
12/12/2023	20:26	Dow Jones News	Caribou Biosciences Shares Rise 4.1% as FDA Approves Lymphoma Trial	NASDAQ:CRBU	Caribou Biosciences Inc
12/12/2023	18:02	GlobeNewswire Inc.	Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024	NASDAQ:CRBU	Caribou Biosciences Inc
17/11/2023	18:06	Edgar (US Regulatory)	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
07/11/2023	18:03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CRBU	Caribou Biosciences Inc
07/11/2023	18:00	GlobeNewswire Inc.	Caribou Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
06/11/2023	10:00	GlobeNewswire Inc.	Caribou Biosciences Announces Appointment of Sundar Jagannath, MD, to its Scientific Advisory Board	NASDAQ:CRBU	Caribou Biosciences Inc
18/10/2023	09:00	GlobeNewswire Inc.	Caribou Biosciences Announces FDA Clearance of IND Application for CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia	NASDAQ:CRBU	Caribou Biosciences Inc
27/09/2023	09:00	GlobeNewswire Inc.	Caribou Biosciences Appoints Reigin Zawadzki as Chief People Officer	NASDAQ:CRBU	Caribou Biosciences Inc
08/08/2023	17:00	GlobeNewswire Inc.	Caribou Biosciences Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:CRBU	Caribou Biosciences Inc
14/07/2023	18:31	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:CRBU	Caribou Biosciences Inc
14/07/2023	17:22	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:CRBU	Caribou Biosciences Inc
14/07/2023	08:51	IH Market News	Friday’s Wall Street Highlights: JPMorgan Chase, Coinbase, UPS, Theseus Pharmaceuticals, and more	NASDAQ:CRBU	Caribou Biosciences Inc
14/07/2023	00:15	GlobeNewswire Inc.	Caribou Biosciences Announces Pricing of Upsized $125 Million Public Offering	NASDAQ:CRBU	Caribou Biosciences Inc